NetworkNewsBreaks

WednesdayFeb 05, 2025 11:56 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Closes $21M Public Offering to Advance Alzheimer’s Drug Development

Annovis Bio (NYSE: ANVS), a late-stage clinical drug company focused on neurodegenerative diseases, announced the closing of its underwritten public offering, raising $21 million in gross proceeds. The offering included 5.25 million shares of common stock and warrants at a combined price of $4.00 per share, with warrants exercisable at $5.00 per share for five years. The company plans to use the funds primarily for the continued Phase 3 development of its lead Alzheimer’s drug, Buntanetap, as well as for working capital and corporate purposes. ThinkEquity acted as the sole book-running manager. To view the full press release, visit https://nnw.fm/D8Tmq…

Continue Reading

WednesdayFeb 05, 2025 11:45 am

NetworkNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Unveils SOBRsure™ Wristband for Alcohol Monitoring

SOBRsafe (NASDAQ: SOBR) has introduced SOBRsure™, a wristband that detects alcohol through transdermal technology, offering real-time monitoring for individuals, families, and businesses. CEO David Gandini emphasized its role as both an accountability tool and a vital resource for those managing sobriety. The global drug screening market is poised for rapid growth, driven by rising substance abuse and stricter regulations. According to the World Drug Report 2023, drug use increased by 23% over a decade, while alcohol-related traffic fatalities in the U.S. rose 14% in a single year. Market forecasts project the industry to reach $19.5 billion by 2029, with North…

Continue Reading

WednesdayFeb 05, 2025 10:50 am

NetworkNewsBreaks – FinovateEurope to Showcase Cutting-Edge Breakthroughs, Solutions for the Future of Fintech

Informa PLC, a London-based events production, digital products and academic research services agency, has announced its plans to host FinovateEurope. The event is slated to take place from Feb. 25-26, 2025, at the Intercontinental O2 Hotel in London, England. As the industry-leading event for market-ready innovations and executive-level networking, FinovateEurope will draw the biggest names across the financial landscape, including from financial institutions, venture capital firms, and fintech or technology companies and solution providers. The event is designed to streamline one-on-one connections with founders, innovators, executives, and experts and offer a unique frame of reference, novel ideas and fresh insight…

Continue Reading

WednesdayFeb 05, 2025 9:10 am

NetworkNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Announces Gold Resource Increase at Fox Complex’s Grey Fox Deposit

McEwen Mining (NYSE: MUX) (TSX: MUX) reported a significant increase in estimated gold resources at the Grey Fox deposit within its Fox Complex, compared to its 2021 estimate. The discovery cost was $14.46 per ounce, with mineralization located near the historically productive Porcupine-Destor fault. The increase is attributed to exploration drilling, a higher gold price assumption of $2,000 per ounce versus $1,725 in 2021, and a lower cut-off grade of 1.60 g/t gold. Chairman Rob McEwen stated that the expanded resources will support higher annual production and extended mine life. A complete resource update is expected in the coming weeks.…

Continue Reading

TuesdayFeb 04, 2025 3:16 pm

NetworkNewsBreaks – Alphabet Inc.’s (NASDAQ: GOOGL) Upcoming Earnings Report: A Look at Expectations and Market Position

Alphabet (NASDAQ: GOOGL, GOOG) is the parent company of Google, a global leader in technology and digital services. The company is set to release its fourth-quarter earnings, with Wall Street analysts expecting revenue of $96.56 billion and earnings per share of $2.13. Alphabet competes with other tech giants like Amazon, Apple and Microsoft. Currently, GOOGL’s stock is priced at $205.05, showing a 1.90% increase, or $3.82, from previous levels. This price movement indicates positive investor sentiment ahead of the earnings report. The stock’s fluctuation between $202.82 and $206.68 during the trading day highlights its volatility, with $206.68 being its highest…

Continue Reading

TuesdayFeb 04, 2025 3:07 pm

NetworkNewsBreaks – BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) Announces Pricing of $3.05M Public Offering

BriaCell (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, has announced the pricing of a best-efforts public offering of 762,500 common shares, each at a public offering price of $4.00. The company expects $3.05 million in total gross proceeds from the offering, of which it intends to use the net for working capital, general corporate purposes, and the advancement of business objectives. Subject to the satisfaction of customary conditions, the offering is expected to close on Feb. 5, 2025. ThinkEquity is acting as the sole placement agent for the offering. To…

Continue Reading

TuesdayFeb 04, 2025 1:55 pm

NetworkNewsBreaks – FAVO Capital Inc. (FAVO) Engages IBN for Corporate Communications Expertise

FAVO Capital (OTC: FAVO) has partnered with IBN, a multifaceted financial media and publishing firm, to enhance its investor communications and expand its market reach. FAVO Capital, a leading provider of alternative financing solutions in the private credit sector, is transforming the industry by expanding funding capacity, enhancing technology-driven underwriting models, and optimizing borrower acquisition strategies to drive market share growth and investor value. As part of its strategic roadmap to uplist to Nasdaq, the company is optimizing its capital structure, strengthening regulatory compliance, and advancing institutional partnerships, while developing a digital platform and mobile app to enhance client engagement.…

Continue Reading

TuesdayFeb 04, 2025 10:46 am

NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Positive Clinical Trial Results for unbuzzd™

Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzd™, significantly accelerates alcohol metabolism and reduces symptoms of intoxication and hangovers. The double-blind, placebo-controlled study showed that unbuzzd™ lowered blood alcohol concentration by over 40% faster within 30 minutes compared to placebo, while improving alertness and stabilizing heart rate and blood pressure. Participants also reported reduced mental fatigue and hangover symptoms without adverse side effects. Quantum BioPharma CEO Zeeshan Saeed highlighted unbuzzd™ as a breakthrough in promoting safe and responsible alcohol consumption. To view the full press release, visit https://nnw.fm/38wS5 About Quantum…

Continue Reading

TuesdayFeb 04, 2025 10:40 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Poised for 3X Growth in 2025 Following Juve Stabia Acquisition

Brera Holdings (NASDAQ: BREA) could see its stock price triple in 2025, according to an updated valuation report from 247MarketNews.com. The report follows BREA’s acquisition of a 51.72% stake in Italian Serie B soccer club Società Sportiva Juve Stabia for $7.7 million, with potential performance-based bonuses of up to $5.65 million. If Juve Stabia remains in Serie B, BREA’s annual revenue is projected to rise by $5.15 million, with an increase to $8.7 million if promoted to Serie A. BREA’s revenue forecast for 2025 has been revised to between $6.3 million and $9.8 million, with expectations reaching $12.62 million by…

Continue Reading

TuesdayFeb 04, 2025 10:27 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) to Begin Construction on First Battery Energy Storage Project

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) announced that construction on its first Battery Energy Storage System project in Ontario will commence the week of Feb. 10, 2025. The SFF-06 project, located in Cramahe, Ontario, is part of a $25.8 million loan agreement with the Royal Bank of Canada. Anvil Crawler Development Corp. was awarded a $1.85 million contract to complete civil and electrical work. The project, which secured a 22-year contract with Ontario’s Independent Electricity System Operator, will have a daily contract capacity of 4.74 MW. SolarBank holds a 50% interest in the project, with…

Continue Reading